Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Peck

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Expert Review of Clinical Pharmacology|November 26, 2011
Clinical pharmacology of tocilizumab for the treatment of patients with rheumatoid arthritisXiaoping Zhang, Richard Peck
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Beyond Genetics-Stratified and Personalised Medicines Using Multiple ParametersRichard Peck, Patrick Smith
Expert Review of Clinical Pharmacology|July 19, 2018
Use of quantitative clinical pharmacology to improve early clinical development success in neurodegenerative diseasesHugo Geerts, Ronald Gieschke, Richard Peck
Clinical Pharmacology and Therapeutics|July 1, 2023
Digital Therapeutics as a New Therapeutic Modality: A Review from the Perspective of Clinical PharmacologyBenjamin Ribba, Richard Peck, Lucy Hutchinson, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 12, 2023
Synthetic Model Combination: A new machine-learning method for pharmacometric model ensemblingAlexander Chan, Richard Peck, Megan Gibbs, et al.
Clinical Pharmacology and Therapeutics|May 27, 2020
Drug Dosing Recommendations for All Patients: A Roadmap for ChangeJ Robert Powell, Jack Cook, Yaning Wang, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2022
OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development PipelineSara E Boyd, Alison Holmes, Richard Peck, et al.
Open Forum Infectious Diseases|February 10, 2018
An Updated Review of Iclaprim: A Potent and Rapidly Bactericidal Antibiotic for the Treatment of Skin and Skin Structure Infections and Nosocomial Pneumonia Caused by Gram-Positive Including Multidrug-Resistant BacteriaDavid B Huang, Catherine D Strader, James S MacDonald, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 14, 2006
Model-based drug development: the road to quantitative pharmacologyLiping Zhang, Vikram Sinha, S Thomas Forgue, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 15, 2018
Models and Machines: How Deep Learning Will Take Clinical Pharmacology to the Next LevelLucy Hutchinson, Bernhard Steiert, Antoine Soubret, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Expert Review of Clinical Pharmacology|November 26, 2011
Clinical pharmacology of tocilizumab for the treatment of patients with rheumatoid arthritisXiaoping Zhang, Richard Peck
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Beyond Genetics-Stratified and Personalised Medicines Using Multiple ParametersRichard Peck, Patrick Smith
Expert Review of Clinical Pharmacology|July 19, 2018
Use of quantitative clinical pharmacology to improve early clinical development success in neurodegenerative diseasesHugo Geerts, Ronald Gieschke, Richard Peck
Clinical Pharmacology and Therapeutics|July 1, 2023
Digital Therapeutics as a New Therapeutic Modality: A Review from the Perspective of Clinical PharmacologyBenjamin Ribba, Richard Peck, Lucy Hutchinson, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 12, 2023
Synthetic Model Combination: A new machine-learning method for pharmacometric model ensemblingAlexander Chan, Richard Peck, Megan Gibbs, et al.
Clinical Pharmacology and Therapeutics|May 27, 2020
Drug Dosing Recommendations for All Patients: A Roadmap for ChangeJ Robert Powell, Jack Cook, Yaning Wang, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2022
OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development PipelineSara E Boyd, Alison Holmes, Richard Peck, et al.
Open Forum Infectious Diseases|February 10, 2018
An Updated Review of Iclaprim: A Potent and Rapidly Bactericidal Antibiotic for the Treatment of Skin and Skin Structure Infections and Nosocomial Pneumonia Caused by Gram-Positive Including Multidrug-Resistant BacteriaDavid B Huang, Catherine D Strader, James S MacDonald, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 14, 2006
Model-based drug development: the road to quantitative pharmacologyLiping Zhang, Vikram Sinha, S Thomas Forgue, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 15, 2018
Models and Machines: How Deep Learning Will Take Clinical Pharmacology to the Next LevelLucy Hutchinson, Bernhard Steiert, Antoine Soubret, et al.
Pageof 3